An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

References

• GoetghebeurMLandryPAHanDVicenteCMethicillin- resistant Staphylococcus aureus: a public health issue with economic consequencesCan J Infect Dis Med Microbiol2007181273418923684
   PubMed Web of Science ®Google Scholar
• RichardsMJEdwardsJRCulverDHGaynesRPNosocomial infections in combined medical-surgical intensive care units in the United StatesInfect Control Hosp Epidemiol200021851051510968716
   PubMed Web of Science ®Google Scholar
• KockRBeckerKCooksonBMethicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in EuropeEuro Surveill201015411968820961515
   PubMedGoogle Scholar
• DiekemaDJPfallerMASchmitzFJSurvey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999Clin Infect Dis200132Suppl 2S114S13211320452
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and ControlEuropean Antimicrobial Resistance Surveillance Network (EARS-Net) Available from: http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspxAccessed April 30, 2014
   Google Scholar
• European Centre for Disease Prevention and ControlAntimicrobial resistance surveillance in Europe 2011Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)Stockholm, SwedenEuropean Centre for Disease Prevention and Control2012 Available from: http://www.ecdc.europa.eu/en/publications/publications/antimicrobial-resistance-surveillance-europe-2011.pdfAccessed November 8, 2013
   Google Scholar
• European Centre for Disease Prevention and ControlHealthcare-associated infections Available from: http://www.ecdc.europa.eu/en/healthtopics/Healthcare-associated_infections/pages/index.aspxAccessed November 20, 2013
   Google Scholar
• GastmeierPGeffersCNosocomial infections in Germany. What are the numbers, based on the estimates for 2006?Dtsch Med Wochenschr20081332111111115 German18478503
   PubMed Web of Science ®Google Scholar
• BakerAMMeredithJWHaponikEFPneumonia in intubated trauma patients. Microbiology and outcomesAm J Respir Crit Care Med199615313433498542141
   PubMed Web of Science ®Google Scholar
• FagonJYChastreJHanceAJMontraversPNovaraAGibertCNosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stayAm J Med19939432812888452152
   PubMed Web of Science ®Google Scholar
• RosenthalVDGuzmanSMigoneOSafdarNThe attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysisAm J Infect Control200533315716115798670
   PubMed Web of Science ®Google Scholar
• CosgroveSEQiYKayeKSHarbarthSKarchmerAWCarmeliYThe impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital chargesInfect Control Hosp Epidemiol200526216617415756888
   PubMed Web of Science ®Google Scholar
• EckmannCLawsonWNathwaniDAntibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteriaInt J Antimicrob Agents2014441566424928311
   PubMed Web of Science ®Google Scholar
• ReedSDFriedmanJYEngemannJJCosts and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremiaInfect Control Hosp Epidemiol200526217518315756889
   PubMed Web of Science ®Google Scholar
• RubinsteinECammarataSOliphantTWunderinkRLinezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter studyClin Infect Dis200132340241211170948
   PubMed Web of Science ®Google Scholar
• WunderinkRGRelloJCammarataSKCroos-DabreraRVKollefMHLinezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumoniaChest200312451789179714605050
   PubMed Web of Science ®Google Scholar
• KollefMHPrevention of hospital-associated pneumonia and ventilator-associated pneumoniaCrit Care Med20043261396140515187525
   PubMed Web of Science ®Google Scholar
• WunderinkRGNiedermanMSKollefMHLinezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled studyClin Infect Dis201254562162922247123
   PubMed Web of Science ®Google Scholar
• OttEBangeFCReichardtCCosts of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureusJ Hosp Infect201076430030320951471
   PubMed Web of Science ®Google Scholar
• De CockEKruegerWASorensenSCost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in GermanyInfection200937212313219277465
   PubMed Web of Science ®Google Scholar
• MullinsCDKuznikAShayaFTCost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusClin Ther20062881184119816982296
   PubMed Web of Science ®Google Scholar
• SolemCNiedermanMSChastreJIN4 Healthcare resource utilization (HCRU) and costs among patients treated for nosocomial pneumonia (NP) caused by methicillin-resistant Staphylococcus aureus (MRSA): Secondary analysis of a multi-center, randomized, controlled studyValue Health2012154A10
   Web of Science ®Google Scholar
• NiedermanMChastreJESolemCIncidence of renal failure and associated economic burden among patients with nosocomial pneumonia caused by methicillin resistant Staphylococcus aureus (MRSA-NP) treated with linezolid or vancomycin: a secondary analysis of a multi-center randomized double-blind clinical trialPaper presented at IDWeek 2012San Diego, CA, USAOctober 17–21, 2012
   Google Scholar
• G-DRG System 2013Institute for Hospital Reimbursement (InEK) Available from: http://www.g-drg.de/cms/G-DRG-System_2013Accessed December 2, 2013
   Google Scholar
• BriggsAHWeinsteinMCFenwickEAKarnonJSculpherMJPaltielADModel parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6Value Health201215683584222999133
   PubMed Web of Science ®Google Scholar
• WunderinkRGMendelsonMHSomeroMSEarly microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureusChest200813461200120718719064
   PubMed Web of Science ®Google Scholar
• RelloJNietoMSoléJSpanish economic analysis of resource-use burden among patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA-NP) treated with linezolid or vancomycin, with a special focus on patients developing renal failurePaper presented at the 23rd European Congress of Clinical Microbiology and Infectious DiseasesBerlin, GermanyApril 27–30, 2013
   Google Scholar
• IMS Health database http://www.imshealth.com/portal/site/imsAccessed October 2, 2013
   Google Scholar